TRDA
Entrada Therapeutics, Inc. · Healthcare
Pres, Research, Develop. Natarajan Sethuraman sold $399K of Entrada Therapeutics, Inc.
Sold$398,810
$15.39Price
25,907Shares
−11%Stake
What TRDA did after the filing
- The stock from Tue, May 5 open, $15.82
- −57.0%
- S&P 500, same days
- +2.7%
Measured over 30 trading days, to the Jun 17 close.
Traded Mon, May 4. Filed Mon, May 4, 7:25 PM ET, after the close. Returns use the May 5 open and the Jun 17 close. Not investment advice.